Abstract: An apparatus, system, and method are disclosed for granting hypervisor privileges. An installation module installs a monitor hypervisor wherein only the monitor hypervisor is granted the hypervisor privileges by the computer. An authentication module authenticates a second hypervisor. An eviction module evicts the monitor hypervisor if the second hypervisor is authenticated. The installation module further installs the second hypervisor after the monitor hypervisor is evicted so that only the second hypervisor is granted hypervisor privileges by the computer.

Abstract: A system, method, and program product is provided that has a virtualized environment provided by a hypervisor. In the virtualized environment, one or more guest operating systems operate simultaneously with a privileged operating system. One of the guest operating systems identifies a device software update, such as a device driver or firmware update, corresponding to a hardware device that is attached to the computer system. The hypervisor is used to notify the privileged operating system of the device software update. When the privileged operating system is notified of the update, the privileged operating system uses one or more techniques to deny the guest operating systems access to the device. The privileged operating system then updates the device software update. After the device software update has been applied, the privileged operating system resumes access between the guest operating systems and the hardware device.

Abstract: The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.

Abstract: The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.

Abstract: A system, method, and program product is provided that uses environments to control access to encryption keys. A request for an encryption key and an environment identifier is received. If the encryption key is not associated with the environment identifier, the request is denied. If they are associated, the system receives user-supplied environment authentication data items from a user. Examples of environment authentication data include passwords, user identifiers, user biometric data (e.g., fingerprint scan, etc.), smart cards, and the like. The system retrieves stored environment authentication data items from a secure (e.g., encrypted) storage location. The retrieved stored environment authentication data items correspond to the environment identifier that was received. The received environment authentication data items are authenticated using the retrieved stored environment authentication data items.

Abstract: An apparatus, system, and method are disclosed for quiescing a boot environment. A reservation module reserves a portion of a first storage device. A store module stores an update boot image to the reserved portion. A detection module detects the update boot image stored on the first storage device when the computer boots and executes the update boot image in place of a standard boot image in response to detecting the update boot image. The update boot image places a computer in a known quiescent state.

Abstract: A system, method, and program product is provided that executes a start sequence of an information handling system that includes a hardware based TPM. Multiple PCRs are stored in the TPM and are initialized to a predetermined state when the start sequence commences. During execution of the start sequence, software modules, including a hypervisor, are loaded the system's memory. PCR values resulting from the loading of the software modules are calculated. The resulting PCR values are compared with expected PCR values. If the PCR values match the expected PCR values, then a virtual environment is created under the hypervisor. The virtual environment includes a VM and a virtual trust platform module (vTPM) that is used by the virtual machine to satisfy the virtual machines TPM requests.

Abstract: The invention partitions the HDD into three areas, namely, no access, write-only, and the conventional read/write. Sensitive data (antivirus programs, back up data, etc.) is written into write-only areas, which thereafter become designated “no access” by appropriately changing their designation a data structure known as “logical block address” or “LBA”. Only users having approved passwords can change the status of a “no access” block back to “write-only” or “read/write”.

Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

Abstract: An approach is provided that identifies when a wireless keyboard unit is connected to an information handling system that includes a display screen that is partially blocked when the keyboard is attached. A determination is made as to the size of the visible portion of the display screen. Items are displayed on the visible portion of the display screen. The approach refrains from displaying items on the blocked portion of the display screen. The user is able to move the wireless keyboard, the movement of the keyboard resulting in a changed size of the visible portion of the display screen. After the keyboard is repositioned, the visual items are re-displayed on the visible portion of the display screen so that the items fit in the changed size of the visible portion of the display screen.

Abstract: A system, method, and program product is provided that detects whether a network adapter has been removed from a computer system. If the network adapter, such as a wireless network adapter, has been removed from the computer system, then a tamper evident indicator (e.g., bit) is set in a nonvolatile memory area of the computer system. In addition, a hard drive password is set to a different password according to a hard drive password policy. The hard drive password controls access to files stored on the hard drive. In one embodiment, the power-on password is also changed to a new password so that the user has to enter the new power-on password when initializing the computer system in order to access the files stored on the computer system.

Abstract: Apparatus, systems, and methods provide digital voice call redirection. A configuration module associates a phone number with a first identifier of a first voice terminal device and a second identifier of a second voice terminal device provided by an address module. A location module determines whether the first device is within a predefined proximity to the second device, such as by detecting connectivity between the devices, over a personal area network (“PAN”). A routing module redirects a digital voice call to a call module of the first device using the first identifier when the first device is not within the predefined proximity to the second device. Otherwise the routing module directs the call to a call module of the second device using the second identifier.

Abstract: A method and apparatus are disclosed for sharing an integrity security module in a dual-environment computing device. The apparatus include an integrity security module, one or more processors, a detection module and a regeneration module. The one or more processors may have access to the integrity security module and may operate in two distinct operating environments of a dual-environment computing device. The detection module may detect, during an initialization sequence, a power state transition of an operating environment of the dual-environment computing device. The regeneration module may regenerate one or more integrity values from a stored integrity metric log in response to detecting the power state transition of the operating environment of the dual-environment computing device.

Abstract: An apparatus, system, and method are disclosed for auditing access to secure data. A detection module detects an access to the secure data. A record module records an encrypted log entry describing the access to the secure data. A verification module verifies the secure data is securely stored.

Abstract: A system and method for authenticating suspect code includes steps of: receiving the suspect code for a first instance of a trusted platform module; loading the suspect code into a trusted platform module device operatively associated with a processor, wherein the suspect code is loaded outside of a shielded location within the trusted platform module device; retrieving a validation public key from a table and storing it in a register in the trusted platform module device, the validation public key indexed by the suspect code; and retrieving a hash algorithm from the table, the hash algorithm indexed by the suspect code. The hash algorithm is run to derive a first hash value; then, using the validation public key, the second hash value is decrypted to derive a second decrypted hash value. The two hash values are compared; and upon determining a match, the suspect code is loaded into the shielded location of the processor for execution by the processor.

Abstract: The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.

Abstract: The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.

Abstract: The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

Abstract: The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.